DigitalHealth.London has been recognised by the Financial Times as one of the leading Accelerators in England for health innovators. DigitalHealth.London has been named as one of England’s top accelerators for health by the Financial…
Continue Reading
Research conducted on the International Space Station (ISS) may result in early cancer detection, advance treatments for neurodegenerative conditions and improve respiratory therapies.Space Station (ISS) on SpaceX’s 31st Commercial Resupply Services (CRS) was on…
Continue Reading
What You Should Know:
– Medidata, a Dassault Systèmes brand and a leader in clinical trial solutions for the life sciences industry, has announced an extended and expanded partnership with Bristol Myers Squibb (BMS).
– This collaboration aims…
Continue Reading
An outage to the EMIS IT system caused “chaos” for GPs in England when access was cut off to appointment booking systems and patient records at the busiest time of the week.
EMIS is the…
The junior ministers responsible for digital, data and MedTech within the Department of Health and Social Care (DHSC) have been announced.
Appointments were made by Wes Streeting, Labour MP for Ilford North, who became health…
Dynamic Therapeutics, a spin-out from the University of Bristol, has been awarded a Blavatnik Prize from venture capital firm QantX, for its pioneering U-RHYTHM technology, which can capture up to 72 samples over 24…
Continue Reading
Five universities have formed a brand new Digital Health Hub, to elevate the south west of England and Wales’ digital health capabilities. The £4.11m hub aims to surface unmet health and care needs and…
Continue Reading
Bristol & Weston NHS Purchasing Consortium (BWPC) has announced it has selected SAP Ariba to drive its digital procurement transformation programme as it embraces a single modern procurement platform in the cloud.The new partnership…
Continue Reading
A study conducted by The University of Texas MD Anderson Cancer Center recommends intensity-modulated radiation therapy (IMRT) as the preferred treatment for locally advanced non-small cell lung cancer (NSCLC). IMRT significantly reduces lung and…
Continue Reading
Viz.ai gains FDA De Novo approval for its AI-driven algorithm detecting hypertrophic cardiomyopathy (HCM). This breakthrough software evaluates electrocardiograms, alerting specialists to suspicious findings for further assessment. The FDA’s recognition establishes a new category…
Continue Reading
